Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster. The Danish drugmaker has ...

Takeda Pharmaceuticals and Lundbeck have jointly announced the submission of a New Drug Application (NDA) to the US FDA for the investigational agent vortioxetine. Vortioxetine (Lu AA21004 ...

Since its acquisition by Novo Holdings in 2023 and The Lundbeck Foundation, Ellab has been expanding its global reach and capabilities to meet the growing needs of the life science sector.

As of March 25 at 4:00:00 PM EDT. Market Open. Loading Chart for HLBBF ...

Send us a tip using our anonymous form. A daily briefing on what matters in the music industry Send us a tip using our anonymous form.